BLLN ▲ +0.1% - BillionToOne, Inc. $BLLN - BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds 07-OCT-2026 07:00 AM ET